Skip to main content

Advertisement

Log in

Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis

  • Original Article
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Purpose

Cerebral venous thrombosis (CVT) is a rare disease in children, characterized by partial or total occlusion of blood flow in the cerebral venous system. The aim of this study is to describe clinical presentation, neuroimaging features, therapeutic management, and outcome of children with CVT.

Methods

We retrospectively analyzed the data, including clinical manifestations, laboratory data, neurological findings, and treatment of children with radiologically confirmed CVT, admitted between January 2010 and March 2020 to our hospital. Cases of CVT complicating brain surgery were excluded.

Results

We enrolled 24 children with CVT. Infection was the main etiology (58.3%), followed by trauma in 16.7% of cases. In the remaining 25% of cases, the cause was identified only in one patient presenting a thrombophilic factor. The most frequent site of thrombosis was the superficial venous system (86.8%), with multiple localizations disclosed in 79% of patients. All children received anticoagulant therapy with low molecular weight heparin (LMWH). One patient died for systemic complications of an underlying disease. No patient developed hemorrhagic events during the therapy, lasting from 35 to 360 days (mean 86 days). In all but one surviving patients (22 out of 24), recanalization of the sinus was observed at AngioMRI performed during follow-up. No neurological complications of CVT were recorded (mean follow-up: 1.5 year).

Conclusions

CVT may present with subtle and unspecific clinical manifestations in children. High level of suspicion should be kept in trauma and sinusitis. Anticoagulation treatment is safe and effective and should be promptly started to improve outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ATIII:

Antithrombin III

CTV:

Computed tomography venography

CVT:

Cerebral venous thrombosis

INR:

International normalized ratio

IQR:

Interquartile range

LMWH:

Low molecular weight heparin

MRI:

Magnetic resonance imaging

MRV:

Magnetic resonance venography

PICU:

Pediatric intensive care unit

TTR:

Target therapeutic range

UFH:

Unfractionated heparin

VKAs:

Vitamin K antagonists

VTE:

Venous thrombosis

Xa:

Activated factor X

References

  1. Barnes C, Newall F, Furmedge J, Mackay M, Monagle P (2004) Cerebral sinus venous thrombosis in children. J Paediatr Child Health 40:53–55

    Article  CAS  Google Scholar 

  2. De Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ et al (2001) Cerebral sinovenous thrombosis in children. N Engl J Med 345:417–423

    Article  Google Scholar 

  3. Ichord R (2017) Cerebral sinovenous thrombosis. Front Pediatr 5:163

    Article  Google Scholar 

  4. Witmer CM, Takemoto CM (2017) Pediatric hospital acquired venous thromboembolism. Front Pediatr 5:198

    Article  Google Scholar 

  5. Gao L, Xu W, Yu X, Cao S, Xu H, Yan F et al (2018) Accuracy of magnetic resonance venography in diagnosing cerebral venous sinus thrombosis. Thromb Res 167:64–73

    Article  CAS  Google Scholar 

  6. Widjaja E, Griffiths PD (2004) Intracranial MR venography in children: normal anatomy and variations. AJNR Am J Neuroradiol 25:1557–1562

    CAS  PubMed  Google Scholar 

  7. Karsy M, Harmer JR, Guan J, Brock A, Ravindra VM, Chung LS et al (2018) Outcomes in adults with cerebral venous sinus thrombosis: a retrospective cohort study. J Clin Neurosci 53:34–40

    Article  Google Scholar 

  8. Wang Y, Meng R, Duan J, Liu G, Chen J, Li S et al (2016) Nephrotic syndrome may be one of the important etiologies of cerebral venous sinus thrombosis. J Stroke Cerebrovasc Dis 25:2415–2422

    Article  Google Scholar 

  9. Slasky SE, Rivaud Y, Suberlak M, Tairu O, Fox AD, Ohman-Strickland P (2017) Venous sinus thrombosis in blunt trauma: incidence and risk factors. J Comput Assist Tomogr 41:891–897

    Article  Google Scholar 

  10. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U et al (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e737S–e801S

    Article  CAS  Google Scholar 

  11. Członkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I (2006) Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29:243–256

    Article  Google Scholar 

  12. Golomb M, Fullerton H, Nowak-Gottl U, Deveber G, International Pediatric Stroke Study Group (2009) Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40:52–57

    Article  Google Scholar 

  13. Ichord R, Benedict S, Chan A, Kirkham FJ, Nowak-Göttl U, International Paediatric Stroke Study Group (2015) Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child 100:174–179

    Article  Google Scholar 

  14. Ichord R (2017) Cerebral sinovenous thrombosis. Front Pediatr 5:1–7

    Article  Google Scholar 

  15. Jordan L, Rafay M, Smith S, Askalan R, Zamel KM, deVeber G et al (2010) Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr 156:704–710

    Article  CAS  Google Scholar 

  16. Dlamini N, Billinghurst L, Kirkham FJ (2010) Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am 21:511–527

    Article  Google Scholar 

  17. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators ISCVT (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670

    Article  Google Scholar 

  18. Qu H, Yang M (2013) Early imaging characteristics of 62 cases of cerebral venous sinus thrombosis. Exp Ther Med 5:233–236

    Article  Google Scholar 

  19. Einhaupl KM, Villringer A, Meister W, Garner C, Pellkofer M, Haberl RL et al (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597–600

    Article  CAS  Google Scholar 

  20. De Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484–488

    Article  Google Scholar 

  21. Monagle P, Cuello C, Augustine C, Bonduel M, Brandão LR, Capman T et al (2018) American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2:3292–3316

    Article  Google Scholar 

  22. Newall F, Branchford B, Male C (2018) Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. J Thromb Haemost 16:196–208

    Article  CAS  Google Scholar 

  23. Greene LALC, Law C, Jung M, Walton S, Ignjatovic V, Monagle P et al (2014) Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 12:1554–1557

    Article  CAS  Google Scholar 

  24. Monagle P, Newall F (2018) Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program 2018:399–404

    Article  Google Scholar 

  25. Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, SURVET Study Investigators et al (2015) Sulodexide for the prevention of recurrent venous thromboembolism: the Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: a multicenter, randomized, double-blind, placebo-controlled trial. Circulation 132:1891–1897

    Article  CAS  Google Scholar 

  26. Cohen O, Levy-Mendelovich S, Ageno W (2020) Rivaroxaban for the treatment of venous thromboembolism in pediatric patients. Expert Rev Cardiovasc Ther 24:1–9

    Google Scholar 

  27. Chhim RF, Shelton CM, Christensen ML (2013) Recent new drug approvals, part 2: drugs undergoing active clinical studies in children. J Pediatr Pharmacol Ther 18:14–38

    PubMed  PubMed Central  Google Scholar 

  28. Male C, Lensing AWA, Palumbo JS et al (2020) Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol 7:e18–e27

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonietta Curatola.

Ethics declarations

Conflict of interest

None.

Ethics approval

This study was approved by the Institutional Review Board and Ethic Committee of our institution.

Consent to participate

All subjects gave their consent to participate in the study.

Consent for publication

All subjects gave their consent to the publication of anonymized data.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lazzareschi, I., Curatola, A., Gatto, A. et al. Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis. Childs Nerv Syst 37, 153–160 (2021). https://doi.org/10.1007/s00381-020-04958-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-020-04958-z

Keywords

Navigation